Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atherothrombotic Diseases”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Early research (Phase 1)Study completedNCT02957448
What this trial is testing

Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects

Who this might be right for
Atherothrombotic Diseases
Bristol-Myers Squibb 16
Post-approval studies (Phase 4)UnknownNCT06102720
What this trial is testing

Efficacy of Colchicine in Preventing Recurrent Stroke in the Patients With Acute Atherothrombotic Ischemic Stroke During Hospitalization

Who this might be right for
Ischemic Stroke
Mikhail Zykov 200
Large-scale testing (Phase 3)Not Yet RecruitingNCT07440381
What this trial is testing

TriPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE

Who this might be right for
Acute Coronary SyndromesSecondary PreventionLipids
Heart Care Foundation 600
Not applicableStudy completedNCT00761969
What this trial is testing

Prevention of Ischemic Events in Patients With Peripheral Arterial Disease

Who this might be right for
Peripheral Arterial Disease
KRKA 1,455
Post-approval studies (Phase 4)Study completedNCT00814268
What this trial is testing

COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke

Who this might be right for
Stroke
Sanofi 358
Post-approval studies (Phase 4)Study completedNCT00819403
What this trial is testing

Simvastatin With or Without Ezetimibe and Atherothrombotic Biomarker Assessment

Who this might be right for
Metabolic Syndrome
University of Maryland, Baltimore 15
Post-approval studies (Phase 4)Study completedNCT02616497
What this trial is testing

ASpirin vs Triflusal for Event Reduction In Atherothrombosis Secondary Prevention (ASTERIAS)

Who this might be right for
Atherothrombosis
University of Ioannina 1,220
Large-scale testing (Phase 3)Study completedNCT01732822
What this trial is testing

A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease

Who this might be right for
Peripheral Artery Disease
AstraZeneca 13,885
Not applicableUnknownNCT02450721
What this trial is testing

Clinical and Laboratory Biomarkers in Patients With Atherothrombotic Stroke

Who this might be right for
Carotid Artery DiseasesStroke
St. Petersburg State Pavlov Medical University 97
Large-scale testing (Phase 3)Study completedNCT00526474
What this trial is testing

Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (P04737)

Who this might be right for
AtherosclerosisIschemiaMyocardial Infarction+2 more
Merck Sharp & Dohme LLC 26,449
Testing effectiveness (Phase 2)Study completedNCT00443755
What this trial is testing

Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance

Who this might be right for
Type 2 DiabetesInsulin ResistanceMetabolic Syndrome
Mayo Clinic 28
Post-approval studies (Phase 4)UnknownNCT00513149
What this trial is testing

Platelet Function Assessment for Atherothrombotic Patients

Who this might be right for
Coronary Artery Disease
National Taiwan University Hospital 150
Large-scale testing (Phase 3)Study completedNCT00050817
What this trial is testing

Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)

Who this might be right for
Arteriosclerosis
Sanofi 15,603
Not applicableStudy completedNCT01183754
What this trial is testing

Use of a Point-of-Care Platelet Function Assay for the Prediction of Atherothrombotic Events

Who this might be right for
Coronary Artery Disease
CardioVascular Research Foundation, Korea 3,000
Not applicableUnknownNCT06020209
What this trial is testing

CCT for Comprehensive Risk Stratification Following STEMI

Who this might be right for
Myocardial Infarction
University of Turin, Italy 200
Not applicableStudy completedNCT04298567
What this trial is testing

Study to Learn More About the Safety and Effectiveness of Rivaroxaban (Xarelto) When Given Together With Acetylsalicylic Acid to Indian People With Narrowing of the Arteries of the Heart (CAD) and/or With Reduced Blood Flow in the Arteries of the Legs and Arms With Symptoms (Symptomatic PAD)

Who this might be right for
Prevention of Atherothrombotic EventsCoronary Artery Disease (CAD)Symptomatic Peripheral Artery Disease (Symptomatic PAD)
Bayer 300
Not applicableStudy completedNCT03034148
What this trial is testing

Platelet Acetyl Coenzyme A Carboxylase Phosphorylation in Coronary Artery Disease

Who this might be right for
Coronary Artery DiseaseAcute Coronary SyndromeCoronary Thrombosis
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 188
Not applicableStudy completedNCT02673437
What this trial is testing

Rivaroxaban ACS Specialist Cohort Event Monitoring Study

Who this might be right for
Acute Coronary Syndrome
Drug Safety Research Unit, Southampton, UK 701
Not applicableStudy completedNCT02684825
What this trial is testing

Detection of Silent Atrial Fibrillation aFter Ischemic StrOke

Who this might be right for
Ischemic StrokeCerebral InfarctionBrain Ischemia+6 more
Danilo Toni 317
Large-scale testing (Phase 3)Looking for participantsNCT06930885
What this trial is testing

Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease

Who this might be right for
Atherothrombotic DiseasesAtherosclerotic Cardiovascular Disease (ASCVD)
Hospital do Coracao 7,713
Next Page